IDegLira Improves Metabolic Control in Patients with Type 2 Diabetes Previously Treated with Premix Insulin

BACKGROUND: IDegLira( fixed combination of GLP 1 receptor agonist and insulin) has been shown to be effective in improving the glucoregulation in patients previously treated with oral therapy as well as individual components, GLP-1 receptor agonist or basal insulin. OBJECTIVE: The aim of this study...

Descripción completa

Detalles Bibliográficos
Autores principales: Bostandzic, Amela Dizdarevic, Beslic, Vanja Karlovic, Surkovic, Ismana, Balic, Sefkija, Dujic, Tanja, Asimi, Zelija Velija, Burekovic, Azra
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Academy of Medical Sciences of Bosnia and Herzegovina 2022
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9233474/
https://www.ncbi.nlm.nih.gov/pubmed/35774039
http://dx.doi.org/10.5455/medarh.2022.76.96-100

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9233474/
https://www.ncbi.nlm.nih.gov/pubmed/35774039
http://dx.doi.org/10.5455/medarh.2022.76.96-100

Ejemplares similares